Plant Comparison
Panax Ginseng vs Guarana
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Panax Ginseng and Guarana: they share 5 indicated uses (cognitive function, fatigue / low energy, memory, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Panax Ginseng | Guarana | Verdict |
|---|---|---|---|
| Cognitive function | 9/10 | 8/10 | Comparable evidence |
| Fatigue / low energy | 8/10 | 9/10 | Comparable evidence |
| Memory | 8/10 | 8/10 | Comparable evidence |
| Metabolic support | 5/10 | 5/10 | Comparable evidence |
| Muscle soreness | 5/10 | 6/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
The dominant bioactive constituent, present at 2-4 times the concentration found in coffee beans by weight; responsible for guarana's stimulant, ergogenic and thermogenic effects.
Polyphenols thought to slow caffeine absorption and to contribute antioxidant activity.
Minor stimulant alkaloids alongside caffeine.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
inferred from neuroprotective action
inferred from ergogenic action
Safety, Cautions & Contraindications
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
Guarana contains very high levels of caffeine (2–4 times that of coffee by weight). All the cautions of caffeine apply — avoid in cardiac arrhythmia, hypertension, anxiety disorders, insomnia, and during pregnancy and breastfeeding. Should not be combined with other stimulants, MAOIs, or medications affected by caffeine. Risk of dependence and withdrawal symptoms with prolonged high-dose use.
Duke (2002) rates guarana as ++ and notes CNS-stimulant, anti-aggregant, diuretic, and thermogenic activities, primarily due to its high caffeine content (3–5%). It has positive chronotropic and inotropic effects on the heart. Duke flags guarana as genotoxic and mutagenic at the experimental level (score 1), which warrants caution with high-dose supplementation. Contraindicated in cardiovascular disease, anxiety disorders, peptic ulcers, and during pregnancy. Interactions include potentiation of other stimulants and anticoagulants (Duke, 2002).
External Ids
Botanical Description
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Woody climbing shrub or liana (Sapindaceae) in its native forest habitat, though often cultivated and pruned as a shrub. Leaves are alternate and pinnately compound with 5 leaflets. Small greenish-white flowers are borne in axillary panicles, followed by a red-orange, three-lobed capsule that splits open to reveal black seeds partly covered by a white aril - a fruit likened in Indigenous Amazonian folklore to a staring eye.
Habitat
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Native to the Amazon basin, particularly Brazil, where it has long been cultivated by Indigenous peoples (notably the Sateré-Mawé); grows in tropical, humid lowland forest conditions.
Harvesting
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Ripe fruit capsules are hand-harvested as they split open; seeds are removed, roasted, and traditionally ground into a paste with water and shaped into sticks for storage, or dried and powdered.
Traditional Uses
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Guarana seed has a long Amazonian Indigenous tradition as a stimulant tonic for fatigue and stamina and as a ceremonial and social beverage. Its very high caffeine content (greater by weight than coffee beans) underlies its modern use for cognitive performance, physical endurance and metabolic support, supported by clinical trials.[5]
Preparations
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
Dosage
References
Drug Class Interactions
Not documented
Pairings
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
Not documented
Lookalikes Review
References & Sources
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
- Hack, B., Penna, E.M., Talik, T., Chandrashekhar, R. and Millard-Stafford, M (2023) 'Effect of Guarana (Paullinia cupana) on Cognitive Performance: A Systematic Review and Meta-Analysis', Nutrients, 15(2), pp. 434. doi:10.3390/nu15020434 Meta-analysis / review
https://doi.org/10.3390/nu15020434 - de Araujo, D.P., Pereira, P.T.V.T., Fontes, A.J.C., Marques, K.D.S. and others (2021) 'The use of guarana (Paullinia cupana) as a dietary supplement for fatigue in cancer patients: a systematic review with a meta-analysis', Supportive Care in Cancer, 29(12), pp. 7171-7182. doi:10.1007/s00520-021-06242-5 Meta-analysis / review
https://doi.org/10.1007/s00520-021-06242-5 - Aldhahrani, A (2021) 'Protective effects of guarana (Paullinia cupana) against methotrexate-induced intestinal damage in mice', Food Science & Nutrition, 9(7), pp. 3397-3404. doi:10.1002/fsn3.2101 Preclinical
https://doi.org/10.1002/fsn3.2101 - Sirena, D.H., Araujo, A.B., Silveira, A.B.T., Serafini, M.A. and others (2024) 'Guarana (Paullinia cupana) as a potential tool for mesenchymal stromal cells priming in regenerative medicine', Brazilian Journal of Medical and Biological Research, 57, pp. e13286. doi:10.1590/1414-431X2024e13286 Preclinical
https://doi.org/10.1590/1414-431X2024e13286 - Torres, E.A.F.S., Pinaffi-Langley, A.C.D.C., Figueira, M.S., Cordeiro, K.S. and others (2022) 'Effects of the consumption of guarana on human health: A narrative review', Comprehensive Reviews in Food Science and Food Safety, 21(1), pp. 272-295. doi:10.1111/1541-4337.12862 Traditional / reference
https://doi.org/10.1111/1541-4337.12862 - Penna, E.M., Harp, A., Hack, B., Talik, T.N. and Millard-Stafford, M (2024) 'Guarana (Paullinia cupana) but Not Low-Dose Caffeine Improves Cycling Time-Trial Performance Versus Placebo', International Journal of Sport Nutrition and Exercise Metabolism, 34(1), pp. 30-37. doi:10.1123/ijsnem.2023-0148 Randomized trial
https://doi.org/10.1123/ijsnem.2023-0148 - Lima, N.D.S., Numata, E.P., Mesquita, L.M.S., Dias, P.H. and others (2017) 'Modulatory Effects of Guarana (Paullinia cupana) on Adipogenesis', Nutrients, 9(6), pp. 635. doi:10.3390/nu9060635 Preclinical
https://doi.org/10.3390/nu9060635 - Lima, N.D.S., Teixeira, L., Gambero, A. and Ribeiro, M.L (2018) 'Guarana (Paullinia cupana) Stimulates Mitochondrial Biogenesis in Mice Fed High-Fat Diet', Nutrients, 10(2), pp. 165. doi:10.3390/nu10020165 Preclinical
https://doi.org/10.3390/nu10020165 - Zamberlan, D.C., Arantes, L.P., Machado, M.L., da Silveira, T.L. and others (2020) 'Guarana (Paullinia cupana Mart.) protects against amyloid-beta toxicity in Caenorhabditis elegans through heat shock protein response activation', Nutritional Neuroscience, 23(6), pp. 444-454. doi:10.1080/1028415X.2018.1517473 Preclinical
https://doi.org/10.1080/1028415X.2018.1517473 - Abboud, R.S., Ribeiro, I.C.A., Pereira, V.A., Correa, L.B.N. and others (2020) 'Guarana (Paullinia cupana) consumption improves hepatic and renal parameters in alloxan-induced diabetic rats', Nutricion Hospitalaria, 37(2), pp. 343-348. doi:10.20960/nh.02759 Preclinical
https://doi.org/10.20960/nh.02759 - Amaral, J.F., Neto, F.R.A., Ferreira, F.M., Leite, E.P. and Andrade, C.M.B (2015) 'Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidants activity in vitro', pp. 174--182. Traditional / reference
https://scholar.google.com/scholar?q=Guarana%20%28Paullinia%20cupana%29%3A%20toxic%20behavioral%20effects%20in%20laboratory%20animals%20and%20antioxidants%20activity%20in%20vitro - Haskell, C.F., Kennedy, D.O., Wesnes, K.A., Milne, A.L. and Scholey, A.B (2007) 'A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guarana in humans', 21(1), pp. 65--70. doi:10.1177/0269881106063815 Randomized trial
https://doi.org/10.1177/0269881106063815 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.